Primary |
Hypertension |
66.7% |
Hypothyroidism |
6.2% |
Osteoporosis |
4.9% |
Blood Cholesterol Increased |
2.5% |
Blood Pressure |
2.5% |
Cardiac Murmur |
2.5% |
Coronary Artery Disease |
2.5% |
Transient Ischaemic Attack |
2.5% |
Asthma |
1.2% |
Benign Prostatic Hyperplasia |
1.2% |
Breast Cancer |
1.2% |
Cerebrovascular Accident |
1.2% |
Dyspepsia |
1.2% |
Pain |
1.2% |
Polycythaemia Vera |
1.2% |
Prophylaxis |
1.2% |
|
Skin Inflammation |
8.5% |
Visual Disturbance |
8.5% |
Skin Burning Sensation |
6.4% |
Throat Irritation |
6.4% |
White Blood Cell Count Decreased |
6.4% |
Diarrhoea |
4.3% |
Dysphagia |
4.3% |
Erythromelalgia |
4.3% |
Food Interaction |
4.3% |
Glycosylated Haemoglobin Increased |
4.3% |
Gout |
4.3% |
Gouty Arthritis |
4.3% |
Hallucination, Visual |
4.3% |
Headache |
4.3% |
Malaise |
4.3% |
Mental Impairment |
4.3% |
Myositis |
4.3% |
Ocular Icterus |
4.3% |
Pancreatic Carcinoma |
4.3% |
Rash |
4.3% |
|
Secondary |
Maternal Exposure Before Pregnancy |
65.8% |
Foetal Exposure During Pregnancy |
14.8% |
Product Used For Unknown Indication |
13.4% |
Hypertension |
4.0% |
Drug Use For Unknown Indication |
1.3% |
Cerebrovascular Accident |
0.7% |
|
Pierre Robin Syndrome |
25.0% |
Maternal Exposure Before Pregnancy |
15.0% |
Respiratory Disorder |
15.0% |
Learning Disability |
5.0% |
Learning Disorder |
5.0% |
Maternal Drugs Affecting Foetus |
5.0% |
Pain |
5.0% |
Renal Disorder |
5.0% |
Renal Failure |
5.0% |
Suicide Attempt |
5.0% |
Visual Impairment |
5.0% |
Withdrawal Syndrome |
5.0% |
|
Concomitant |
Product Used For Unknown Indication |
34.2% |
Hypertension |
20.0% |
Drug Use For Unknown Indication |
9.9% |
Prostate Cancer |
4.4% |
Schizophrenia |
4.4% |
Pain |
2.9% |
Breast Cancer Metastatic |
2.6% |
Constipation |
2.3% |
Diffuse Large B-cell Lymphoma |
2.3% |
Crohn's Disease |
2.1% |
Rheumatoid Arthritis |
2.1% |
Angina Pectoris |
1.7% |
Hypothyroidism |
1.7% |
Breast Cancer |
1.6% |
Pneumonia |
1.6% |
Prophylaxis |
1.4% |
Blood Pressure Increased |
1.3% |
Diabetes Mellitus |
1.2% |
Mineral Supplementation |
1.2% |
Nausea |
1.2% |
|
Weight Decreased |
10.0% |
Loss Of Consciousness |
8.8% |
Vomiting |
8.8% |
Headache |
7.5% |
Pyrexia |
7.5% |
Keloid Scar |
6.3% |
Transient Ischaemic Attack |
5.0% |
White Blood Cell Count Decreased |
5.0% |
Electrocardiogram Qt Interval Abnormal |
3.8% |
Electrocardiogram Qt Prolonged |
3.8% |
Intestinal Stenosis |
3.8% |
Renal Failure Acute |
3.8% |
Rhabdomyolysis |
3.8% |
Skin Irritation |
3.8% |
Syncope |
3.8% |
Tinnitus |
3.8% |
Tremor |
3.8% |
Asthma |
2.5% |
Breast Lump Removal |
2.5% |
Chest Discomfort |
2.5% |
|